MedPath

Edgewood Oncology, Inc.

Edgewood Oncology, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2023-01-01
Employees
1
Market Cap
-
Website
http://www.edgewoodoncology.com

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (100.0%)

A Study of BTX-A51 in People With Advanced Solid Tumor and Breast Cancer

Phase 1
Recruiting
Conditions
Advanced Solid Tumor
Metastatic Breast Cancer
Interventions
First Posted Date
2021-05-04
Last Posted Date
2025-03-25
Lead Sponsor
Edgewood Oncology Inc.
Target Recruit Count
112
Registration Number
NCT04872166
Locations
🇺🇸

Florida Cancer Specialists, Sarasota, Florida, United States

🇺🇸

The Linder Research Center at The Christ Hospital, Cincinnati, Ohio, United States

🇺🇸

SCRI Oncology Partners, Nashville, Tennessee, United States

and more 2 locations

A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Phase 1
Recruiting
Conditions
Acute Myeloid Leukemia
Myelodysplastic Syndrome
Interventions
First Posted Date
2020-01-28
Last Posted Date
2024-03-20
Lead Sponsor
Edgewood Oncology Inc.
Target Recruit Count
80
Registration Number
NCT04243785
Locations
🇺🇸

City of Hope National Medical Center, Duarte, California, United States

🇺🇸

Memorial Sloan-Kettering Cancer Center, New York, New York, United States

🇺🇸

The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

News

No news found
© Copyright 2025. All Rights Reserved by MedPath